8/109 sources · 8 publishersUpdated Nov 5, 12:16 UTC
Cardinal Health reports Q1 FY2027 results and lifts FY2027 non‑GAAP EPS outlook
Cardinal Health announced first‑quarter FY2027 revenue of $67.5 billion, a 5% year‑over‑year increase. GAAP diluted EPS rose 27% to $2.38 and non‑GAAP diluted EPS rose 28% to $3.26. The company raised its FY2027 non‑GAAP EPS guidance to a range of $12.80‑$13.00, up from $12.40‑$12.60, and completed a $500 million share repurchase program.
Why it matters
The higher guidance signals stronger earnings expectations for the full fiscal year, which may support the stock price. The $500 million buyback reduces share count, potentially boosting future EPS.
Key facts
- 1Q1 FY2027 revenue increased 5% to $67.5 billion prnewswire.com
- 2GAAP diluted EPS increased 27% to $2.38 prnewswire.com
- 3Non‑GAAP diluted EPS increased 28% to $3.26 prnewswire.com
- 4FY2027 non‑GAAP EPS guidance raised to $12.80‑$13.00 prnewswire.com
- 5Company completed a $500 million share repurchase program in Q1 prnewswire.com
- 6Non‑GAAP effective tax rate lowered to 18.5%‑19.5% for FY2027 guidance sec.gov
Summary written by AlphAI AI Desk from 9 of 9 sources. Not investment advice. Figures are as stated by the linked sources.